Literature DB >> 25331458

Reduced retention of Pittsburgh compound B in white matter lesions.

Lidia Glodzik1, Henry Rusinek, Jinyu Li, Cyrus Zhou, Wai Tsui, Lisa Mosconi, Yi Li, Ricardo Osorio, Schantel Williams, Catherine Randall, Nicole Spector, Pauline McHugh, John Murray, Elizabeth Pirraglia, Shankar Vallabhajolusa, Mony de Leon.   

Abstract

PURPOSE: One of the interesting features of the amyloid tracer Pittsburgh compound B (PiB) is that it generates a signal in the white matter (WM) in both healthy subjects and cognitively impaired individuals. This characteristic gave rise to the possibility that PiB could be used to trace WM pathology. In a group of cognitively healthy elderly we examined PiB retention in normal-appearing WM (NAWM) and WM lesions (WML), one of the most common brain pathologies in aging.
METHODS: We segmented WML and NAWM on fluid attenuation inversion recovery (FLAIR) images of 73 subjects (age 61.9 ± 10.0, 71 % women). PiB PET images were corrected for partial volume effects and coregistered to FLAIR images and WM masks. WML and NAWM PiB signals were then extracted.
RESULTS: PiB retention in WML was lower than in NAWM (p < 0.001, 14.6 % reduction). This was true both for periventricular WML (p < 0.001, 17.8 % reduction) and deep WML (p = 0.001, 7.5 % reduction).
CONCLUSION: PiB binding in WM is influenced by the presence of WML, which lower the signal. Our findings add to the growing evidence that PiB can depict WM pathology and should prompt further investigations into PiB binding targets in WM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25331458      PMCID: PMC4415610          DOI: 10.1007/s00259-014-2897-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

Review 1.  White matter hyperintensities in mid-adult life.

Authors:  Perminder Sachdev; Xiaohua Chen; Wei Wen
Journal:  Curr Opin Psychiatry       Date:  2008-05       Impact factor: 4.741

2.  A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology.

Authors:  Melissa E Murray; Prashanthi Vemuri; Greg M Preboske; Matthew C Murphy; Katherine J Schweitzer; Joseph E Parisi; Clifford R Jack; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

3.  Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes.

Authors:  P Bech; M Kastrup; O J Rafaelsen
Journal:  Acta Psychiatr Scand Suppl       Date:  1986

4.  White matter hyperintensities predict amyloid increase in Alzheimer's disease.

Authors:  Timo Grimmer; Maximilian Faust; Florian Auer; Panagiotis Alexopoulos; Hans Förstl; Gjermund Henriksen; Robert Perneczky; Christian Sorg; Behrooz H Yousefi; Alexander Drzezga; Alexander Kurz
Journal:  Neurobiol Aging       Date:  2012-03-10       Impact factor: 4.673

5.  Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

Authors:  Bruno Stankoff; Leorah Freeman; Marie-Stéphane Aigrot; Audrey Chardain; Frédéric Dollé; Anna Williams; Damien Galanaud; Lucie Armand; Stéphane Lehericy; Catherine Lubetzki; Bernard Zalc; Michel Bottlaender
Journal:  Ann Neurol       Date:  2011-02-18       Impact factor: 10.422

6.  White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Authors:  Frank A Provenzano; Jordan Muraskin; Giuseppe Tosto; Atul Narkhede; Ben T Wasserman; Erica Y Griffith; Vanessa A Guzman; Irene B Meier; Molly E Zimmerman; Adam M Brickman
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

7.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

Review 8.  Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis.

Authors:  George Harauz; Noboru Ishiyama; Christopher M D Hill; Ian R Bates; David S Libich; Christophe Farès
Journal:  Micron       Date:  2004       Impact factor: 2.251

9.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

10.  Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.

Authors:  Young T Hong; Tonny Veenith; Deborah Dewar; Joanne G Outtrim; Vaithianadan Mani; Claire Williams; Sally Pimlott; Peter J A Hutchinson; Adriana Tavares; Roberto Canales; Chester A Mathis; William E Klunk; Franklin I Aigbirhio; Jonathan P Coles; Jean-Claude Baron; John D Pickard; Tim D Fryer; William Stewart; David K Menon
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

View more
  18 in total

1.  Separation of β-amyloid binding and white matter uptake of (18)F-flutemetamol using spectral analysis.

Authors:  Kerstin Heurling; Christopher Buckley; Rik Vandenberghe; Koen Van Laere; Mark Lubberink
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

2.  Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Authors:  Burcu Zeydan; Val J Lowe; Christopher G Schwarz; Scott A Przybelski; Nirubol Tosakulwong; Samantha M Zuk; Matthew L Senjem; Jeffrey L Gunter; Rosebud O Roberts; Michelle M Mielke; Eduardo E Benarroch; Moses Rodriguez; Mary M Machulda; Timothy G Lesnick; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci; Orhun H Kantarci
Journal:  Mult Scler       Date:  2017-05-05       Impact factor: 6.312

3.  White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition.

Authors:  Val J Lowe; Emily S Lundt; Matthew L Senjem; Christopher G Schwarz; Hoon-Ki Min; Scott A Przybelski; Kejal Kantarci; David Knopman; Ronald C Petersen; Clifford R Jack
Journal:  J Nucl Med       Date:  2018-04-19       Impact factor: 10.057

4.  Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.

Authors:  Alexis Moscoso; Michel J Grothe; Michael Schöll
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-21       Impact factor: 9.236

5.  Statistical Parametric Mapping in Amyloid Positron Emission Tomography.

Authors:  Natasha M Smith; Jeremy N Ford; Arsalan Haghdel; Lidia Glodzik; Yi Li; Debra D'Angelo; Arindam RoyChoudhury; Xiuyuan Wang; Kaj Blennow; Mony J de Leon; Jana Ivanidze
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.702

6.  Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.

Authors:  Anna M Pietroboni; Tiziana Carandini; Annalisa Colombi; Matteo Mercurio; Laura Ghezzi; Giovanni Giulietti; Marta Scarioni; Andrea Arighi; Chiara Fenoglio; Milena A De Riz; Giorgio G Fumagalli; Paola Basilico; Maria Serpente; Marco Bozzali; Elio Scarpini; Daniela Galimberti; Giorgio Marotta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-21       Impact factor: 9.236

7.  The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension.

Authors:  Jose-Alberto Palma; Gabriel Redel-Traub; Angelo Porciuncula; Daniela Samaniego-Toro; Patricio Millar Vernetti; Yvonne W Lui; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Parkinsonism Relat Disord       Date:  2020-05-18       Impact factor: 4.891

Review 8.  Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.

Authors:  Kerstin Heurling; Antoine Leuzy; Eduardo R Zimmer; Mark Lubberink; Agneta Nordberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-06       Impact factor: 9.236

9.  Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease.

Authors:  Tomotaka Tanaka; Mary C Stephenson; Ying-Hwey Nai; Damian Khor; Francis N Saridin; Saima Hilal; Steven Villaraza; Bibek Gyanwali; Masafumi Ihara; Henri Vrooman; Ashley A Weekes; John J Totman; Edward G Robins; Christopher P Chen; Anthonin Reilhac
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-20       Impact factor: 9.236

10.  Associations of β-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort.

Authors:  Sarah E Keuss; William Coath; Jennifer M Nicholas; Teresa Poole; Josephine Barnes; David M Cash; Christopher A Lane; Thomas D Parker; Ashvini Keshavan; Sarah M Buchanan; Aaron Z Wagen; Mathew Storey; Matthew Harris; Ian B Malone; Carole H Sudre; Kirsty Lu; Sarah-Naomi James; Rebecca Street; David L Thomas; John C Dickson; Heidi Murray-Smith; Andrew Wong; Tamar Freiberger; Sebastian Crutch; Marcus Richards; Nick C Fox; Jonathan M Schott
Journal:  Neurology       Date:  2022-04-11       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.